Please enter your license information:
Efficacy Profile
A1C at 24 weeks graph full text
- A1C graph showing the demonstrated mean change in A1C for Trajenta® (n=333) and placebo (n=163) over 24 weeks.
- Y-axis shows the mean (SE, or standard error) change from baseline in A1C percent over time from 7.0% to 8.5%. Treatment duration in weeks is on the x-axis, as follows: baseline, 6, 12, 18, 24.
- Line shows demonstrated reductions in A1C from baseline through to Week 24 for Trajenta® compared to an increase in A1C for placebo. Demonstrated difference from placebo in A1C was -0.69% at Week 24 (p<0.0001). Change from baseline was -0.44% for Trajenta® and +0.25% for placebo.
Are you thinking Trajenta®?
![Healthcare professional and patient Healthcare professional and patient](https://pro.boehringer-ingelheim.com/ca/products/trajenta/images/login-banner-updated.png)
Are you a Canadian
View coverage details for Trajenta® and Jentadueto®
![Map of Canada Map of Canada](https://pro.boehringer-ingelheim.com/ca/products/trajenta/images/check-coverage-icon.png)